We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
10 Year Est. Return
AUM
$6.44B
AUM Growth
+$259M
Cap. Flow
+$405M
Cap. Flow %
6.29%
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$206M
2
CVS icon
CVS Health
CVS
+$122M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$102M
4
MCK icon
McKesson
MCK
+$80.6M
5
PCRX icon
Pacira BioSciences
PCRX
+$45.1M

Sector Composition

Rank Sector Weight
1 Healthcare 49.63%
2 Energy 5.88%
3 Consumer Discretionary 5.63%
4 Financials 4.88%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBLU icon
1051
CALL
JetBlue
JBLU
$2.13B
$9K ﹤0.01%
7,200
-182,000
-96% -$1.68M
FLIR
1052
PUT
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$9K ﹤0.01%
+5,800
New +$203K
MW
1053
PUT
DELISTED
THE MENS WAREHOUSE INC
MW
$9K ﹤0.01%
+60,400
New +$3.07M
ESRX
1054
CALL
DELISTED
Express Scripts Holding Company
ESRX
$8K ﹤0.01%
+50,000
New +$3.52M
DTV
1055
CALL
DELISTED
DIRECTV COM STK (DE)
DTV
$8K ﹤0.01%
+9,200
New +$750K
CTRA
1056
CALL
DELISTED
Coterra Energy
CTRA
$6K ﹤0.01%
116,600
-38,000
-25% -$1.36M
NVRI icon
1057
PUT
Enviri
NVRI
$624M
$6K ﹤0.01%
+6,700
New +$171K
ZU
1058
PUT
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$6K ﹤0.01%
+11,200
New +$451K
SPY icon
1059
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$5K ﹤0.01%
45,700
-226,200
-83% -$43M
ARNA
1060
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5K ﹤0.01%
+18,500
New +$1.16M
NSR
1061
CALL
DELISTED
Neustar Inc
NSR
$5K ﹤0.01%
+22,800
New +$620K
COV
1062
CALL
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5K ﹤0.01%
+92,800
New +$6.94M
OIH icon
1063
PUT
VanEck Oil Services ETF
OIH
$1.97B
$2K ﹤0.01%
+3,750
New +$3.96M
IDIX
1064
PUT
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$2K ﹤0.01%
+92,800
New +$967K
OPEN
1065
PUT
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
$1K ﹤0.01%
+46,300
New +$3.53M
A icon
1066
CALL
Agilent Technologies
A
$39.6B
-431,143
Closed -$17.2M
ACAD icon
1067
Acadia Pharmaceuticals
ACAD
$4.51B
-227,936
Closed -$5.55M
ACGL icon
1068
Arch Capital
ACGL
$36.5B
-22,110
Closed -$425K
ADP icon
1069
Automatic Data Processing
ADP
$109B
-11,422
Closed -$775K
AEP icon
1070
American Electric Power
AEP
$70.4B
-635,138
Closed -$32.2M
AFG icon
1071
American Financial Group
AFG
$11.9B
-3,532
Closed -$204K
AGCO icon
1072
AGCO
AGCO
$8.41B
-58,516
Closed -$3.23M
AIZ icon
1073
Assurant
AIZ
$13.9B
-5,250
Closed -$342K
ANF icon
1074
Abercrombie & Fitch
ANF
$4.55B
-6,937
Closed -$268K
ASB icon
1075
Associated Banc-Corp
ASB
$5.8B
-12,240
Closed -$222K

Similar funds

Visium Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Visium Asset Management deployed $405M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.

  • Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
  • Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
  • Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
  • Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
  • Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
  • Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
  • Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.

Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.